Literature DB >> 32347205

Narcolepsy and COVID-19: sleeping on an opportunity?

Fabian-Xosé Fernandez1,2, Julie Flygare3, Michael A Grandner4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32347205      PMCID： PMC7446099          DOI： 10.5664/jcsm.8520

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  5 in total

Review 1.  Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy.

Authors:  Roland S Liblau; Anne Vassalli; Ali Seifinejad; Mehdi Tafti
Journal:  Lancet Neurol       Date:  2015-02-16       Impact factor: 44.182

2.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

Review 3.  Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment.

Authors:  Claudio L A Bassetti; Antoine Adamantidis; Denis Burdakov; Fang Han; Steffen Gay; Ulf Kallweit; Ramin Khatami; Frits Koning; Brigitte R Kornum; Gert Jan Lammers; Roland S Liblau; Pierre H Luppi; Geert Mayer; Thomas Pollmächer; Takeshi Sakurai; Federica Sallusto; Thomas E Scammell; Mehdi Tafti; Yves Dauvilliers
Journal:  Nat Rev Neurol       Date:  2019-07-19       Impact factor: 42.937

Review 4.  The autoimmune basis of narcolepsy.

Authors:  Josh Mahlios; Alberto K De la Herrán-Arita; Emmanuel Mignot
Journal:  Curr Opin Neurobiol       Date:  2013-05-29       Impact factor: 6.627

5.  Reduced number of hypocretin neurons in human narcolepsy.

Authors:  T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173
  5 in total
  2 in total

1.  Narcolepsy risk and COVID-19.

Authors:  Emmanuel Mignot; Steve Black
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

Review 2.  The COVID-19 pandemic, an environmental neurology perspective.

Authors:  J Reis; A Buguet; G C Román; P S Spencer
Journal:  Rev Neurol (Paris)       Date:  2022-03-22       Impact factor: 4.313
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.